image
Healthcare - Biotechnology - NASDAQ - US
$ 0.953
-5.94 %
$ 39.2 M
Market Cap
-3.28
P/E
Price Target Average
--100.00%
Revenue Forecast Estimate
-0.00%
EBIT Estimate
25.99%
Net Income Estimate
58.52%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Anebulo Pharmaceuticals, Inc.
image
ANEB has no price targets from Wall Street.
REVENUE FORECAST

Revenue Forecast Chart ANEB

image
$80.0m$80.0m$70.0m$70.0m$60.0m$60.0m$50.0m$50.0m$40.0m$40.0m$30.0m$30.0m$20.0m$20.0m$10.0m$10.0m$0.0$0.02024202420252025202620262027202720282028
EBIT FORECAST

EBIT Forecast Chart ANEB

image
$0.0$0.0($5.0m)($5.0m)($10.0m)($10.0m)($15.0m)($15.0m)($20.0m)($20.0m)($25.0m)($25.0m)($30.0m)($30.0m)($35.0m)($35.0m)2024202420252025202620262027202720282028
NET INCOME FORECAST

Net Income Chart ANEB

image
$20.0m$20.0m$15.0m$15.0m$10.0m$10.0m$5.0m$5.0m$0.0$0.0($5.0m)($5.0m)($10.0m)($10.0m)($15.0m)($15.0m)($20.0m)($20.0m)($25.0m)($25.0m)($30.0m)($30.0m)($35.0m)($35.0m)2024202420252025202620262027202720282028